Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system ...
Sep 8, 2020
0
6
Many types of human cancers exhibit changes in kinase and phosphatase balances. Drugs that inhibit kinase activity have shown success in the clinic as cancer therapeutics, but the phosphatases still remain a largely underexploited ...
Aug 12, 2020
0
157
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and squamous cell carcinomas (HNSCC) account for the majority of these cases. In a new study, based on preclinical research and published ...
Jul 31, 2020
0
18
Does fasting help make chemotherapy more effective in breast cancer patients? Researchers led by Leiden University Medical Centre (LUMC) and Breast Cancer Research Group (BOOG) are a step closer to answering that question ...
Jun 25, 2020
0
57
A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...
Jun 20, 2020
0
196
Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow. More importantly, they have also discovered a way to "turn it off" and inhibit cancer ...
Jun 2, 2020
0
7663
These days, in the era of personalized medicine, whenever researchers discover a new cancer drug they are expected to show exactly how it works and to prove that it is exerting its therapeutic effect by hitting a particular ...
Mar 3, 2020
0
10
Researchers at Columbia Engineering have engineered probiotics to safely deliver immunotherapies within tumors. These include nanobodies against two proven therapeutic targets—PD-L1 and CTLA-4. The drugs are continuously ...
Feb 12, 2020
0
203
Developing a therapy to combat cancer remains one of the most difficult challenges in medical research. Cancer cells use the host's own immune system to grow and spread, ultimately becoming deadly. Immune cells like macrophages, ...
Jan 30, 2020
0
9
Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, ...
Dec 3, 2019
0
4
